JBC:基质金属蛋白酶1a(MMP1)促进肿瘤发生及转移

2012-05-19 Deepblue 生物谷

基质金属蛋白酶(MMP)是水解细胞外基质的蛋白裂解酶。MMPs几乎能降解ECM中的各种蛋白成分,破坏肿瘤细胞侵袭的组织学屏障,在肿瘤侵袭转移中起关键性作用,从而在肿瘤浸润转移中的作用日益受到重视,被认为是该过程中主要的蛋白水解酶。 基质金属蛋白酶1(MMP1),是一种胶原蛋白酶及G蛋白偶联的蛋白酶激活受体1(PAR1)的激活因子,是近年来新发现的一个与肿瘤形成及迁移有关的靶点。然而在老鼠癌症模型

基质金属蛋白酶(MMP)是水解细胞外基质的蛋白裂解酶。MMPs几乎能降解ECM中的各种蛋白成分,破坏肿瘤细胞侵袭的组织学屏障,在肿瘤侵袭转移中起关键性作用,从而在肿瘤浸润转移中的作用日益受到重视,被认为是该过程中主要的蛋白水解酶。

基质金属蛋白酶1(MMP1),是一种胶原蛋白酶及G蛋白偶联的蛋白酶激活受体1(PAR1)的激活因子,是近年来新发现的一个与肿瘤形成及迁移有关的靶点。然而在老鼠癌症模型,MMP1的功能同源物还不明确。

近日,来自美国塔芙茨医学中心的研究人员Athan Kuliopulos等人发现,基质金属蛋白酶1a(Mmp1a)是老鼠的MMP1功能同源物,能够促进肺癌及黑色素瘤的发生及转移。相关论文发表在5月9日的The Journal of Biological Chemistry

研究发现,Lewis肺癌(LLC1)以及老鼠原发性黑色素瘤细胞含有激活的BRAF,能够高水平的表达内源性Mmp1a。

在三维培养基质,沉默Mmp1a或PAR1后会抑制肺癌细胞的侵袭性生长。相反的,在没有表达内源性Mmp1a的上皮细胞,Mmp1a的异位表达会使上皮细胞表现出侵袭表型。

与Mmp1a作为PAR1的激活因子一致,抑制或者是沉默PAR1会失去Mmp1a介导的侵袭表型。

在肿瘤的异种移植模型,敲除Mmp1a后,肿瘤的生成、入侵及转移发生显著减少。

总的来说,该研究表明,癌细胞衍生的Mmp1a作为MMP1的一个功能同源物,赋予了细胞的致癌及转移能力。

doi: 10.1074/jbc.M112.356303
PMC:
PMID:

Matrix metalloprotease-1a promotes tumorigenesis and metastasis

Caitlin J. Foley, Chi Luo, Katie O'Callaghan, Philip W. Hinds, Lidija Covic and Athan Kuliopulos.

Matrix metalloprotease-1 (MMP1), a collagenase and activator of the G protein-coupled protease activated receptor-1 (PAR1), is an emerging new target implicated in oncogenesis and metastasis in diverse cancers.However, the functional mouse homologue of MMP1 in cancer models has not yet been clearly defined. We report here that Mmp1a is a functional MMP1 homologue that promotes invasion and metastatic progression of mouse lung cancer and melanoma.Lewis lung carcinoma (LLC1), and primary mouse melanoma cells harboring active BRAF, express high levels of endogenous Mmp1a which is required for invasion through collagen.Silencing of either Mmp1a or PAR1 suppressed invasive stellate growth of lung cancer cells in 3-dimensional matrices. Conversely, ectopic expression of Mmp1a conferred an invasive phenotype in epithelial cells that do not express endogenous Mmp1a.Consistent with Mmp1a acting as a PAR1 agonist in an autocrine loop, inhibition or silencing of PAR1 resulted in a loss of the Mmp1a-driven invasive phenotype.Knockdown of Mmp1a on tumor cells resulted in significantly decreased tumorigenesis, invasion, and metastasis in xenograft models. Together, these data demonstrate that cancer cell-derived Mmp1a acts as a robust functional homologue of MMP1 by conferring pro-tumorigenic and metastatic behavior to cells.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054439, encodeId=2bb92054439a5, content=<a href='/topic/show?id=bd9b4218475' target=_blank style='color:#2F92EE;'>#基质金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42184, encryptionId=bd9b4218475, topicName=基质金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Sat Nov 10 01:14:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757030, encodeId=32181e57030fa, content=<a href='/topic/show?id=103b421e0e8' target=_blank style='color:#2F92EE;'>#基质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42170, encryptionId=103b421e0e8, topicName=基质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=281337296540, createdName=ms7899726347904398, createdTime=Mon Feb 25 13:14:00 CST 2013, time=2013-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945122, encodeId=c5b8194512221, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88760, encryptionId=249488e60fe, topicName=蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Mar 13 19:14:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036362, encodeId=d2a2203636269, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Feb 01 17:14:00 CST 2013, time=2013-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019885, encodeId=12c02019885fc, content=<a href='/topic/show?id=5a6d961841b' target=_blank style='color:#2F92EE;'>#金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96184, encryptionId=5a6d961841b, topicName=金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QTZ947pojXuchvvmkkJN0wyBBbA3LVX2WDkgiaJ7cswu9yvA4CB0NicjcrCfBY1zRPkA/132, createdBy=b3812500089, createdName=ms6897892027066920, createdTime=Sun Apr 21 10:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054439, encodeId=2bb92054439a5, content=<a href='/topic/show?id=bd9b4218475' target=_blank style='color:#2F92EE;'>#基质金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42184, encryptionId=bd9b4218475, topicName=基质金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Sat Nov 10 01:14:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757030, encodeId=32181e57030fa, content=<a href='/topic/show?id=103b421e0e8' target=_blank style='color:#2F92EE;'>#基质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42170, encryptionId=103b421e0e8, topicName=基质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=281337296540, createdName=ms7899726347904398, createdTime=Mon Feb 25 13:14:00 CST 2013, time=2013-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945122, encodeId=c5b8194512221, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88760, encryptionId=249488e60fe, topicName=蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Mar 13 19:14:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036362, encodeId=d2a2203636269, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Feb 01 17:14:00 CST 2013, time=2013-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019885, encodeId=12c02019885fc, content=<a href='/topic/show?id=5a6d961841b' target=_blank style='color:#2F92EE;'>#金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96184, encryptionId=5a6d961841b, topicName=金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QTZ947pojXuchvvmkkJN0wyBBbA3LVX2WDkgiaJ7cswu9yvA4CB0NicjcrCfBY1zRPkA/132, createdBy=b3812500089, createdName=ms6897892027066920, createdTime=Sun Apr 21 10:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2054439, encodeId=2bb92054439a5, content=<a href='/topic/show?id=bd9b4218475' target=_blank style='color:#2F92EE;'>#基质金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42184, encryptionId=bd9b4218475, topicName=基质金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Sat Nov 10 01:14:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757030, encodeId=32181e57030fa, content=<a href='/topic/show?id=103b421e0e8' target=_blank style='color:#2F92EE;'>#基质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42170, encryptionId=103b421e0e8, topicName=基质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=281337296540, createdName=ms7899726347904398, createdTime=Mon Feb 25 13:14:00 CST 2013, time=2013-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945122, encodeId=c5b8194512221, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88760, encryptionId=249488e60fe, topicName=蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Mar 13 19:14:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036362, encodeId=d2a2203636269, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Feb 01 17:14:00 CST 2013, time=2013-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019885, encodeId=12c02019885fc, content=<a href='/topic/show?id=5a6d961841b' target=_blank style='color:#2F92EE;'>#金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96184, encryptionId=5a6d961841b, topicName=金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QTZ947pojXuchvvmkkJN0wyBBbA3LVX2WDkgiaJ7cswu9yvA4CB0NicjcrCfBY1zRPkA/132, createdBy=b3812500089, createdName=ms6897892027066920, createdTime=Sun Apr 21 10:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2054439, encodeId=2bb92054439a5, content=<a href='/topic/show?id=bd9b4218475' target=_blank style='color:#2F92EE;'>#基质金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42184, encryptionId=bd9b4218475, topicName=基质金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Sat Nov 10 01:14:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757030, encodeId=32181e57030fa, content=<a href='/topic/show?id=103b421e0e8' target=_blank style='color:#2F92EE;'>#基质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42170, encryptionId=103b421e0e8, topicName=基质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=281337296540, createdName=ms7899726347904398, createdTime=Mon Feb 25 13:14:00 CST 2013, time=2013-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945122, encodeId=c5b8194512221, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88760, encryptionId=249488e60fe, topicName=蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Mar 13 19:14:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036362, encodeId=d2a2203636269, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Feb 01 17:14:00 CST 2013, time=2013-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019885, encodeId=12c02019885fc, content=<a href='/topic/show?id=5a6d961841b' target=_blank style='color:#2F92EE;'>#金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96184, encryptionId=5a6d961841b, topicName=金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QTZ947pojXuchvvmkkJN0wyBBbA3LVX2WDkgiaJ7cswu9yvA4CB0NicjcrCfBY1zRPkA/132, createdBy=b3812500089, createdName=ms6897892027066920, createdTime=Sun Apr 21 10:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
    2013-02-01 lily1616
  5. [GetPortalCommentsPageByObjectIdResponse(id=2054439, encodeId=2bb92054439a5, content=<a href='/topic/show?id=bd9b4218475' target=_blank style='color:#2F92EE;'>#基质金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42184, encryptionId=bd9b4218475, topicName=基质金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Sat Nov 10 01:14:00 CST 2012, time=2012-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757030, encodeId=32181e57030fa, content=<a href='/topic/show?id=103b421e0e8' target=_blank style='color:#2F92EE;'>#基质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42170, encryptionId=103b421e0e8, topicName=基质)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=281337296540, createdName=ms7899726347904398, createdTime=Mon Feb 25 13:14:00 CST 2013, time=2013-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945122, encodeId=c5b8194512221, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88760, encryptionId=249488e60fe, topicName=蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Mar 13 19:14:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036362, encodeId=d2a2203636269, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Feb 01 17:14:00 CST 2013, time=2013-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019885, encodeId=12c02019885fc, content=<a href='/topic/show?id=5a6d961841b' target=_blank style='color:#2F92EE;'>#金属蛋白酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96184, encryptionId=5a6d961841b, topicName=金属蛋白酶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QTZ947pojXuchvvmkkJN0wyBBbA3LVX2WDkgiaJ7cswu9yvA4CB0NicjcrCfBY1zRPkA/132, createdBy=b3812500089, createdName=ms6897892027066920, createdTime=Sun Apr 21 10:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]

相关资讯

Nature:研究者发现新的黑色素瘤突变基因-PREX2

PREX2是一个在黑色素瘤中发现的突变的基因(Credit: Alexei Protopopov) 黑色素瘤是一种致命的而且最具有攻击性的皮肤癌症,被认为和长期暴露在太阳光之下有关。近日,来自美国Dana-Farber癌症研究所和布罗德研究所的研究人员对25个转移性黑色素肿瘤进行了全基因组的测序,研究者证实了慢性的太阳光暴露在发展为黑色素瘤中的重要作用,并且揭示了黑色素瘤发生的重要遗传改变。相关

Lancet Onco:全球六分之一癌症与感染有关

近日,新一期英国学术刊物《柳叶刀—肿瘤》The Lancet Oncology 刊登报告说,一项调查显示全球癌症病例中约六分之一由可预防或治疗的感染引起,这凸显了通过防治感染来减少癌症发病率的重要性。 这份报告由位于法国的国际癌症研究机构完成,该机构调查了2008年全球184个国家的27种癌症的数据。当年总计有1270万个新发癌症病例,分析显示,其中约200万个病例是由可预防或治疗的感染

PLoS ONE:肺癌分子亚型和遗传变异可能有助于个性化治疗

针对特定疾病的分子亚型的癌症疗法能帮助医生调整治疗病人的个性化治疗。但科学家们发现,许多类型的癌症分子亚型比以前认为的那样更加多样化,包含进一步的遗传改变,这些变化可以影响病人的治疗反应。 以UNC为首的科学家小组首次证明患者有遗传变异导致的肺癌分子亚型会对对治疗有不同反应。这些研究结果是基于临床前模型和患者的肿瘤样本得来的,研究总结了三个非小细胞肺癌的分子亚型,并改进了对肿瘤亚型的分子分析。

PRSBBS:消失的乳腺癌基因之谜

近日,来自阿德莱德大学的研究者试图去了解乳腺癌和卵巢癌妇女自身突变的基因为什么不传递给下一代。尽管乳腺癌基因和增加的妇女生殖能力两者之间存在某种联系,研究者Jack da Silva表示,因为携带乳腺癌基因的妇女能够多产,理论上,这些妇女应该有很大的机会将癌症基因传递给下一代;可是近来美国的一项研究表明,乳腺癌基因BRCA1和BRCA2突变后会导致妇女的生育能力增加50%。 随着生育能力比例的增

NEJM:肿瘤内异质性和分支进化揭示肿瘤的复杂性

最近由英国伦敦癌症研究所的Marco Gerlinger博士发表的一项严谨的基因组学研究,进一步强调可以将癌症视为癌细胞的异质性集合,这些癌细胞不断进化,甚至可能以达尔文的方式为争取生存权和发展权而发生竞争,而代价是宿主的健康乃至生命。相关论文由近期的New England Journal of Medicine发表。 当上世纪90年代,主流观点认为癌症的起因是单个细胞的突变(常由烟草或射线暴露

Sci Transl Med:病毒性皮肤癌的分子治疗

近日,研究人员在发现一种罕见的皮肤癌病毒的根源四年后,匹兹堡大学癌症研究所(UPCI)大学医学院的研究人员现在已经确定了这种病毒,在动物实验中,可以针对有选择性地激活一个分子杀死肿瘤细胞。这一研究成果将很快被测试患者的治疗。 Moore医学博士说细胞癌(MCC),皮肤癌是常见于中老年人和免疫系统虚弱的人,并且不能轻易诊断出来,它仍然有一个非常差的预后,相关研究论文在5月9日的Science Tr